Neuroprotective Effect of Resveratrol via Activation of Sirt1 Signaling in a Rat Model of Combined Diabetes and Alzheimer’s Disease

85Citations
Citations of this article
98Readers
Mendeley users who have this article in their library.

Abstract

Background: Alzheimer’s disease (AD) and diabetes mellitus (DM) often coexist in patients because having one of these conditions increases risk for the other. These two diseases share several pathophysiological mechanisms, such as specific inflammatory signaling pathways, oxidative stress, and cell apoptosis. It is still unclear exactly which mechanisms associated with DM are responsible for increased AD risk. Studies have found that even transient elevation of brain Aβ levels can allow T2DM to slightly disrupt the neural milieu in a way that encourages pathologies associated with the onset of memory deficits and AD. A recent study argues that a potential common pathogenetic mechanism underlying both DM and AD is evidenced by the cooccurrence of amyloid brain legions and deposits containing both tau and Aβ in pancreatic β cells. Given these links, an investigation detailing disease mechanisms as well as treatment options for patients with cooccurring DM and AD is urgently needed. The biological effects of resveratrol relevant to DM and AD treatment include its abilities to modulate oxidative stress and reduce inflammation. A rat model of DM and concomitant AD was created for this study using intraperitoneal injection of streptozotocin and hippocampal injection of Aβ1–40 to characterize resveratrol’s potential protective action. Results: Resveratrol significantly increased the Sirt1 expression, inhibited the memory impairment, the increased acetylcholinesterase, malondialdehyde, interleukin-1β and interleukin 6 levels, and the decreased levels of choline acetyltransferase (ChAT), superoxide dismutase (SOD), and glutathione in this rat model of diabetes and concomitant AD. The Sirt 1 inhibitor EX527 partially reversed the effects of resveratrol. Conclusion: This study suggests that resveratrol may have a neuroprotective action through activation of Sirt1 signaling in diabetes and AD with concurrent onset.

References Powered by Scopus

A new and rapid colorimetric determination of acetylcholinesterase activity

24026Citations
N/AReaders
Get full text

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045

5380Citations
N/AReaders
Get full text

Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease

1730Citations
N/AReaders
Get full text

Cited by Powered by Scopus

The Beneficial Roles of SIRT1 in Neuroinflammation-Related Diseases

216Citations
N/AReaders
Get full text

SIRT1 Activation by Natural Phytochemicals: An Overview

191Citations
N/AReaders
Get full text

SIRT1 and SIRT2 Activity Control in Neurodegenerative Diseases

126Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Ma, X. R., Sun, Z. K., Han, X., Li, S., Jiang, X., Chen, S., … Lu, H. (2020). Neuroprotective Effect of Resveratrol via Activation of Sirt1 Signaling in a Rat Model of Combined Diabetes and Alzheimer’s Disease. Frontiers in Neuroscience, 13. https://doi.org/10.3389/fnins.2019.01400

Readers over time

‘20‘21‘22‘23‘24‘2507142128

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 35

78%

Professor / Associate Prof. 5

11%

Lecturer / Post doc 3

7%

Researcher 2

4%

Readers' Discipline

Tooltip

Pharmacology, Toxicology and Pharmaceut... 10

29%

Biochemistry, Genetics and Molecular Bi... 9

26%

Neuroscience 8

23%

Agricultural and Biological Sciences 8

23%

Article Metrics

Tooltip
Mentions
News Mentions: 1
Social Media
Shares, Likes & Comments: 55

Save time finding and organizing research with Mendeley

Sign up for free
0